Sharps Compliance to be acquired by PE firm after recent CEO change


The news sent Sharps' stock price skyrocketing nearly 200%, reaching its highest level since November 2021.

Previous Plakous Therapeutics looks to raise $10M for regenerative medicine drug after getting $310,000 from NC Biotech
Next Star Metals lands 'super high brow' rooftop restaurant from Atlanta industry veteran